Uneingeschränkter Zugang

Transthyretin -Related Familial Amyloid Polyneuropathy (TTR-FAP) Polineuropathy – Challenge Diagnosis and Case Presentation


Zitieren

1. Cortese A, Vegezzi E, Lozza A, Alfonsi E, Montini A, Moglia A, et al. Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathy. J Neurol Neurosurg Psychiatry. 2017;88(5):457-8.10.1136/jnnp-2016-315262 Search in Google Scholar

2. Simmons Z, Blaivas M, Aguilera AJ, Feldman EL, Bromberg MB, Towfighi J. Low diagnostic yield of sural nerve biopsy in patients with peripheral neuropathy and primary amyloidosis. J Neurol Sci. 1993;120(1):60-3.10.1016/0022-510X(93)90025-T Search in Google Scholar

3. Kollmer J, Weiler M, Purrucker J, Hegenbart U, Schönland S, Kimmich C, et al. MRNeurography of the sural nerve in patients with hereditary amyloidosis. Orphanet Journal of Rare Diseases. 2015;10(1):P40.10.1186/1750-1172-10-S1-P40 Search in Google Scholar

4. Jercan A, Ene A, Jurcut R, Draghici M, Badelita S, Dragomir M, et al. Clinical characteristics in patients with hereditary amyloidosis with Glu54Gln transthyretin identified in the Romanian population. Orphanet Journal of Rare Diseases. 2020;15(1):34.10.1186/s13023-020-1309-9699331332000831 Search in Google Scholar

5. Alport AR, Sander HW. Clinical approach to peripheral neuropathy: anatomic localization and diagnostic testing. Continuum (Minneap Minn). 2012;18(1):13-38. Search in Google Scholar

6. Nehashi T, Oikawa M, Amami K, Kanno Y, Yokokawa T, Misaka T, et al. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant. Int Heart J. 2019;60(6):1441-3.10.1536/ihj.19-13431666456 Search in Google Scholar

7. Emdin M, Aimo A, Rapezzi C, Fontana M, Perfetto F, Seferović PM, et al. Treatment of cardiac transthyretin amyloidosis: an update. European Heart Journal. 2019;40(45):3699-706.10.1093/eurheartj/ehz29831111153 Search in Google Scholar

8. Coelho T, Merlini G, Bulawa CE, Fleming JA, Judge DP, Kelly JW, et al. Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis. Neurology and Therapy. 2016;5(1):1-25.10.1007/s40120-016-0040-x491913026894299 Search in Google Scholar

9. Mazzeo A, Russo M, Di Bella G, Minutoli F, Stancanelli C, Gentile L, et al. Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area. J Neuromuscul Dis. 2015;2(s2):S39-S48.10.3233/JND-150091527142127858761 Search in Google Scholar

eISSN:
1841-4036
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
4 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Medizin, Klinische Medizin, andere